Status:

Do Not Prescribe (DNP)

Decision Date:

May 2025

Comments

NICE TA1058 - (terminated appraisal) Tislelizumab in combination for untreated advanced non-small-cell lung cancer

NICE TA1068 (terminated appraisal) Tislelizumab for treating unresectable advanced oesophageal squamous cell cancer after platinum-based chemotherapy (Decision date July 2025)

NICE TA1072 (terminated appraisal) Tislelizumab for treating advanced non-small-cell lung cancer after platinum-based chemotherapy (Decision date July 2025)

Do Not Prescribe (DNP) Drug Classifications

• 6: Have NICE guidance that recommends they should not be used

search again